Literature DB >> 6406240

Diazepam-induced release of behavior in an extinction procedure: its reversal by Ro 15-1788.

M H Thiébot, M Childs, P Soubrié, P Simon.   

Abstract

The effects of the benzodiazepine receptor antagonist Ro 15-1788, an imidazobenzodiazepine derivative, were studied with respect to three pharmacological activities exerted by diazepam in rats. Two of these, release of shock-induced suppression of drinking and attenuation of non-reward-induced cessation of responding for food, reflect the anxiolytic property of benzodiazepines. The amnesic-like effect of diazepam was also investigated. Ro 15-1788 (in doses ranging from 4 to 16 mg/kg p.o.) completely reversed diazepam (2 mg/kg)-induced release of behavior in both punishment and non-reward procedures. In contrast, Ro 15-1788 reduced but did not completely abolish diazepam-induced amnesia. These data suggest that the anticonflict and anti-frustration effects of benzodiazepines probably involve similar receptor types which nevertheless differ from those chiefly implicated in the amnesic-like activity of benzodiazepines.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6406240     DOI: 10.1016/0014-2999(83)90398-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Safety signal withdrawal: a behavioural paradigm sensitive to both "anxiolytic" and "anxiogenic" drugs under identical experimental conditions.

Authors:  M H Thiébot; L Dangoumau; G Richard; A J Puech
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt.

Authors:  Miroslav M Savić; Dragan I Obradović; Nenad D Ugresić; James M Cook; P V V S Sarma; Dubravko R Bokonjić
Journal:  Psychopharmacology (Berl)       Date:  2005-02-18       Impact factor: 4.530

Review 3.  Intrinsic actions of the benzodiazepine receptor antagonist Ro 15-1788.

Authors:  S E File; S Pellow
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Effects of lorazepam on memory, attention and sedation in man: antagonism by Ro 15-1788.

Authors:  G C Preston; C E Ward; P Broks; M Traub; S M Stahl
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 5.  The signal attenuation rat model of obsessive-compulsive disorder: a review.

Authors:  Daphna Joel
Journal:  Psychopharmacology (Berl)       Date:  2006-07       Impact factor: 4.530

6.  Neuropharmacology of a new potential anxiolytic compound, F 2692, 1-(3'-trifluoromethyl phenyl) 1,4-dihydro 3-amino 4-oxo 6-methyl pyridazine. 1. Acute and in vitro effects.

Authors:  M B Assié; P Chopin; A Stenger; C Palmier; M Briley
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Dose-dependent reversal of chlordiazepoxide-induced discrimination impairment by Ro 15-1788.

Authors:  S O Cole
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

8.  Corticotropin releasing factor and amphetamine exaggerate partial agonist properties of benzodiazepine antagonist Ro 15-1788 in the conflict test.

Authors:  K T Britton; G Lee; G F Koob
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.